BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12145648)

  • 1. AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line.
    Faili A; Aoufouchi S; Guéranger Q; Zober C; Léon A; Bertocci B; Weill JC; Reynaud CA
    Nat Immunol; 2002 Sep; 3(9):815-21. PubMed ID: 12145648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation.
    Pham P; Bransteitter R; Petruska J; Goodman MF
    Nature; 2003 Jul; 424(6944):103-7. PubMed ID: 12819663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What role for AID: mutator, or assembler of the immunoglobulin mutasome?
    Reynaud CA; Aoufouchi S; Faili A; Weill JC
    Nat Immunol; 2003 Jul; 4(7):631-8. PubMed ID: 12830138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines.
    Rückerl F; Busse B; Bachl J
    Mol Immunol; 2006 Apr; 43(10):1645-52. PubMed ID: 16310251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand.
    Ramiro AR; Stavropoulos P; Jankovic M; Nussenzweig MC
    Nat Immunol; 2003 May; 4(5):452-6. PubMed ID: 12692548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
    Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
    Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription-targeted DNA deamination by the AID antibody diversification enzyme.
    Chaudhuri J; Tian M; Khuong C; Chua K; Pinaud E; Alt FW
    Nature; 2003 Apr; 422(6933):726-30. PubMed ID: 12692563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil.
    Kavli B; Andersen S; Otterlei M; Liabakk NB; Imai K; Fischer A; Durandy A; Krokan HE; Slupphaug G
    J Exp Med; 2005 Jun; 201(12):2011-21. PubMed ID: 15967827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
    Durandy A; Peron S; Taubenheim N; Fischer A
    Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation.
    Durandy A
    Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets.
    Chaudhuri J; Khuong C; Alt FW
    Nature; 2004 Aug; 430(7003):992-8. PubMed ID: 15273694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for Msh6 but not Msh3 in somatic hypermutation and class switch recombination.
    Martomo SA; Yang WW; Gearhart PJ
    J Exp Med; 2004 Jul; 200(1):61-8. PubMed ID: 15238605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does AID need another aid?
    Honjo T
    Nat Immunol; 2002 Sep; 3(9):800-1. PubMed ID: 12205466
    [No Abstract]   [Full Text] [Related]  

  • 14. T cells can induce somatic mutation in B cell receptor-engaged BL2 Burkitt's lymphoma cells independently of CD40-CD40 ligand interactions.
    Denépoux S; Fournier N; Péronne C; Banchereau J; Lebecque S
    J Immunol; 2000 Feb; 164(3):1306-13. PubMed ID: 10640744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation.
    McBride KM; Gazumyan A; Woo EM; Barreto VM; Robbiani DF; Chait BT; Nussenzweig MC
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8798-803. PubMed ID: 16723391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutations and activation-induced cytidine deaminase (AID) expression in established rheumatoid factor-producing lymphoblastoid cell line.
    Gil Y; Levy-Nabot S; Steinitz M; Laskov R
    Mol Immunol; 2007 Jan; 44(4):494-505. PubMed ID: 16574227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation.
    Basu U; Chaudhuri J; Alpert C; Dutt S; Ranganath S; Li G; Schrum JP; Manis JP; Alt FW
    Nature; 2005 Nov; 438(7067):508-11. PubMed ID: 16251902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone inhibits activation-induced deaminase by binding to the promoter.
    Pauklin S; Petersen-Mahrt SK
    J Immunol; 2009 Jul; 183(2):1238-44. PubMed ID: 19553525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
    Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
    J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflections on the state of play in somatic hypermutation.
    Steele EJ
    Mol Immunol; 2008 May; 45(10):2723-6. PubMed ID: 18359085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.